Tricholoma matsutake polypeptide as well as preparation method and application thereof
By using a natural eutectic solvent for heating extraction and enzymatic hydrolysis, high-yield matsutake peptides were prepared, solving the problems of low extraction rate and large activity loss in traditional methods. This method achieves environmentally friendly and efficient matsutake peptide preparation, suitable for food and cosmetics.
Patent Information
- Application Number
- CN202411372553.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-29
- Publication Date
- 2024-11-22
AI Technical Summary
Existing methods for extracting matsutake peptides suffer from low extraction rates, significant loss of activity, and environmental unfriendliness. Traditional alkaline extraction processes severely damage the physicochemical properties of proteins and peptides, making it difficult to meet the demand for efficient preparation of antioxidant, anti-inflammatory, and anti-aging products.
Matsutake polypeptides were prepared by heating and extraction using a natural eutectic solvent (NaDES) combined with enzymatic hydrolysis. The NaDES solvent was used to break the cell walls and increase the dissolution of active ingredients, followed by enzymatic hydrolysis to obtain high yields of matsutake polypeptides.
This method improves the extraction rate of matsutake peptides and enhances their antioxidant, anti-inflammatory, and anti-aging activities, while providing an environmentally friendly preparation method suitable for food and cosmetic applications.
Smart Images

Figure BDA0005067955460000091 
Figure BDA0005067955460000101 
Figure HDA0005067955470000011
Abstract
Description
Technical Field
[0001] The invention belongs to the field of extraction technology, and in particular relates to a Tricholoma matsutake polypeptide and a preparation method and application thereof. Background Art
[0002] As people's consumption level increases, "healthy aging" has gradually developed into a new development market, and the population consuming anti-aging products has gradually expanded and become younger. Aging is a complex, multi-stage, and gradual process that occurs throughout the life process. From the outside, aging is manifested as skin aging; from the inside, aging is manifested as cell aging, body metabolism, and system operation dysfunction. Scientists have deeply analyzed the aging process and influencing factors of the human body from different dimensions to reveal the aging mechanism. Among them, oxidative stress and inflammatory response are one of the endogenous factors of body aging. Excessive oxidative stress response will cause the body to produce a large number of free radicals, inactivate antioxidant enzymes, and the free radicals cannot be removed in time, which will cause serious cell apoptosis and tissue damage, thereby accelerating aging. In addition, relevant studies have shown that inflammatory response is inseparable from aging. From a cellular level, immune cells are the key regulators of aging cells and are responsible for clearing aging cells. When immune cells are aging, they cannot clear aging cells and pro-inflammatory factors, and the level of inflammation will increase accordingly; and when low-level chronic inflammation gradually accumulates, it will further aggravate aging and form a vicious circle. Therefore, in order to delay the aging of the body from the root and achieve the goal of healthy aging, we can regulate it through two major pathways: antioxidant and anti-inflammatory.
[0003] In recent years, bioactive peptides have been widely studied and applied due to their good antioxidant, anti-inflammatory, anti-sugar and anti-cancer activities. Among them, edible fungi have high edible and medicinal value and are rich in protein, which can be used as an important source of bioactive peptides. Related studies have shown that edible fungi peptides such as shiitake peptides, Agaricus bisporus peptides, and Versicolor peptides have good antioxidant, antibacterial, antihypertensive, anti-tumor and immunomodulatory physiological activities. Matsutake, a pure, natural, precious and rare medicinal and edible fungus, contains active components such as proteins, peptides, polysaccharides, polyphenols and vitamins, and has antioxidant, anti-inflammatory, immunomodulatory and anti-tumor effects. However, in recent years, the research on the extraction of effective components of Matsutake has mainly focused on components such as polysaccharides and polyphenols, and there are few studies on the extraction of Matsutake peptides and related physiological activities.
[0004] Traditional methods for extracting bioactive peptides are to first use alkali to extract and purify proteins, and then perform enzymatic hydrolysis to obtain small-molecule bioactive peptides. However, the traditional alkali extraction process is highly toxic, which not only causes certain damage to the physical and chemical properties of proteins and peptides, reducing their efficacy and activity, but also lacks environmental sustainability and has great limitations in application. Summary of the invention
[0005] The purpose of the present invention is to overcome the shortcomings of the above-mentioned prior art and provide a Tricholoma matsutake polypeptide with high yield and excellent antioxidant, anti-inflammatory and anti-aging activities, as well as a preparation method and application thereof.
[0006] To achieve the above object, in a first aspect of the present invention, the present invention provides a method for preparing a Tricholoma matsutake polypeptide, the preparation method comprising the following steps:
[0007] (1) adding pine mushroom powder to a natural low eutectic (NaDES) solvent for heating and extraction, centrifuging after the extraction, and collecting the supernatant;
[0008] (2) adding protease to the supernatant for enzymatic hydrolysis, followed by enzyme inactivation, centrifugation, and ultrafiltration to obtain Tricholoma matsutake polypeptide;
[0009] The raw materials of the natural low eutectic solvent include a hydrogen bond donor, a hydrogen bond acceptor and water, the hydrogen bond donor includes at least one of propylene glycol, butanediol and ethylene glycol, and the hydrogen bond acceptor includes matrine.
[0010] The present invention first uses NaDES solvent for heating extraction, which can effectively break the wall and increase the dissolution of effective ingredients in the matsutake. Subsequently, protease is added to the filtrate after the heating extraction for enzymatic hydrolysis, thereby obtaining matsutake polypeptides with high yield and excellent antioxidant, anti-inflammatory and anti-aging activities.
[0011] As a preferred embodiment of the preparation method of the present invention, the preparation method of the pine mushroom powder is: take the pine mushroom and place it at 45-55°C to dry for 12-14 hours, crush it and pass it through a 5-25 mesh sieve to obtain the pine mushroom powder.
[0012] As a preferred embodiment of the preparation method of the present invention, in the natural low eutectic solvent, the molar ratio of the hydrogen bond acceptor to the hydrogen bond donor is 1:(0.1-5).
[0013] Preferably, in the natural low eutectic solvent, the molar ratio of the hydrogen bond acceptor to the hydrogen bond donor is 1:(1-5).
[0014] As a preferred embodiment of the preparation method of the present invention, the mass percentage of water in the natural low eutectic solvent is 40-95%.
[0015] As a preferred embodiment of the preparation method of the present invention, the preparation method of the natural low eutectic solvent is: after mixing the hydrogen bond donor and the hydrogen bond acceptor, heat to 30-60°C and stir for 3-6h, then add water and stir evenly to obtain the natural low eutectic solvent.
[0016] The NaDES solvent provided by the present invention is a green natural environment-optimized solvent. When the solvent is used as an extraction solvent, the extraction conditions are mild and the solvent has good biosafety. Furthermore, when the molar ratio of the hydrogen bond donor and the hydrogen bond acceptor of the raw materials in the NaDES solvent is selected within the range given by the present invention and the NaDES solvent is prepared by the preparation method provided by the present invention, the obtained NaDES solvent can have a better extraction rate when applied to subsequent extraction.
[0017] As a preferred embodiment of the preparation method of the present invention, in the step (1), the temperature of the heating extraction is 30-60° C., and the time of the heating extraction is 1-3 h.
[0018] As a preferred embodiment of the preparation method of the present invention, in the step (1), the mass volume ratio of the pine mushroom powder to the natural low eutectic solvent is 1: (10-60).
[0019] The present invention has found that the temperature of the heating extraction and the solid-liquid ratio during the extraction process will also affect the extraction rate and the comprehensive performance of the extracted substances. When the extraction temperature, time and solid-liquid ratio are further selected within the above range, the obtained extraction rate is higher and the comprehensive performance of the product is better.
[0020] As a preferred embodiment of the preparation method of the present invention, in the step (1), the centrifugal speed is 8000-12000 r / min, and the centrifugal time is 8-12 min.
[0021] As a preferred embodiment of the preparation method of the present invention, the protease includes at least one of alkaline protease, neutral protease, trypsin and papain.
[0022] Preferably, the protease is an alkaline protease.
[0023] The present invention has found that when the selected protease is of the above type, especially alkaline protease, the yield of the obtained Tricholoma matsutake polypeptide is higher.
[0024] As a preferred embodiment of the preparation method of the present invention, in the step (2), the enzymatic hydrolysis temperature is 35-65°C, and the enzymatic hydrolysis time is 1-3h.
[0025] As a preferred embodiment of the preparation method of the present invention, the mass ratio of the protease to the pine mushroom powder is 1: (4-20).
[0026] The present invention has found that the parameters in the enzymatic hydrolysis process will also affect the enzymatic hydrolysis efficiency and the antioxidant and anti-inflammatory activities of the prepared Tricholoma matsutake polypeptide. When the enzymatic hydrolysis parameters are further selected within the above range, the comprehensive performance of the obtained product is better.
[0027] As a preferred embodiment of the preparation method of the present invention, in the step (2), before enzymatic hydrolysis, the step of adjusting the enzymatic hydrolysis system to a suitable pH value range for the corresponding protease using 0.1 mol / L hydrochloric acid is also included.
[0028] As a preferred embodiment of the preparation method of the present invention, in the step (2), the temperature for inactivating the enzyme is 90-100° C., and the time for inactivating the enzyme is 8-12 min.
[0029] As a preferred embodiment of the preparation method of the present invention, in the step (2), the molecular weight of the ultrafiltration membrane used in ultrafiltration is 10 kDa.
[0030] In a second aspect of the present invention, the present invention provides a Tricholoma matsutake polypeptide, which is prepared by the preparation method of the present invention.
[0031] In the third aspect of the present invention, the present invention provides the use of the Tricholoma matsutake polypeptide in the preparation of antioxidant, anti-inflammatory and anti-aging products.
[0032] As a preferred embodiment of the application of the present invention, the products include food and cosmetics.
[0033] Compared with the prior art, the present invention has the following beneficial effects:
[0034] The present invention first uses NaDES solvent for heating extraction, which can effectively break the wall and increase the dissolution of effective ingredients in Tricholoma matsutake, and then adds protease to the filtrate after heating extraction for enzymolysis, so as to obtain Tricholoma matsutake polypeptide with high yield and excellent antioxidant activity, anti-inflammatory activity and anti-aging activity. The obtained Tricholoma matsutake polypeptide can be used in the preparation of antioxidant, anti-inflammatory or anti-aging products; and the preparation method of Tricholoma matsutake polypeptide provided by the present invention is simple to operate and is conducive to actual production. BRIEF DESCRIPTION OF THE DRAWINGS
[0035] Figure 1 The SEM images of different pine mushroom powders are as follows:
[0036] a- SEM image of untreated Tricholoma matsutake powder, b- SEM image of Tricholoma matsutake powder after water extraction in comparative example 1, c- SEM image of Tricholoma matsutake powder after extraction with sodium hydroxide aqueous solution in comparative example 2, d- SEM image of Tricholoma matsutake powder after extraction with NaDES solvent in example 1. DETAILED DESCRIPTION
[0037] In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with specific embodiments.
[0038] Unless otherwise specified, the reagents, methods and equipment used in the present invention are all conventional reagents, methods and equipment in the art; and unless otherwise specified, the raw materials used in parallel experiments are from the same batch of raw materials.
[0039] Example 1
[0040] The embodiment of the present invention provides a Tricholoma matsutake polypeptide, and the preparation method of the Tricholoma matsutake polypeptide comprises the following steps:
[0041] (1) Dry the matsutake mushrooms at 50°C for 12 h, and sieve through a 10-mesh sieve to obtain matsutake mushroom powder;
[0042] (2) Preparation of NaDES solvent: matrine and propylene glycol were mixed in a molar ratio of 1:3, heated and stirred at 60° C. for 4 h to obtain a viscous liquid, and deionized water was then added to the viscous liquid to obtain a 5% NaDES solvent (i.e., the mass percentage of water in the NaDES solvent is 95%).
[0043] (3) adding the pine mushroom powder in step (1) to the NaDES solvent in step (2) at a solid-liquid ratio of 1:20, then heating to 60° C. and stirring for extraction for 2 h. After the extraction, centrifuging at 10,000 r / min for 10 min and collecting the supernatant;
[0044] (4) Add alkaline protease to the supernatant (the mass ratio of alkaline protease to pine mushroom powder is 1:5), adjust the pH to 9-10, heat to 55°C for enzymatic hydrolysis for 1.5 hours, and after the enzymatic hydrolysis is completed, heat to 100°C to inactivate the enzyme for 10 minutes, then cool, centrifuge, and filter through a 10 kDa filter membrane to obtain pine mushroom polypeptides.
[0045] Example 2
[0046] The embodiment of the present invention provides a Tricholoma matsutake polypeptide. The only difference between the preparation method of the Tricholoma matsutake polypeptide and that of Example 1 is that in step (2), ethylene glycol is used instead of propylene glycol.
[0047] Example 3
[0048] The embodiment of the present invention provides a Tricholoma matsutake polypeptide. The only difference between the preparation method of the Tricholoma matsutake polypeptide and that of Example 1 is that in step (2), propylene glycol is replaced by butylene glycol.
[0049] Example 4
[0050] The embodiment of the present invention provides a Tricholoma matsutake polypeptide. The only difference between the preparation method of the Tricholoma matsutake polypeptide and that of Example 1 is that in step (2), the molar ratio of matrine to propylene glycol is 1:1, and the mass percentage of water is 40%.
[0051] Example 5
[0052] The embodiment of the present invention provides a Tricholoma matsutake polypeptide. The only difference between the preparation method of the Tricholoma matsutake polypeptide and that of Example 1 is that in step (2), the molar ratio of matrine to propylene glycol is 1:5, and the mass percentage of water is 65%.
[0053] Example 6
[0054] The embodiment of the present invention provides a Tricholoma matsutake polypeptide. The only difference between the preparation method of the Tricholoma matsutake polypeptide and that of Example 1 is that in step (3), the Tricholoma matsutake powder in step (1) is added to the NaDES solvent in step (2) at a solid-liquid ratio of 1:60, followed by heating to 30°C and stirring for extraction for 1 hour. After the extraction is completed, the mixture is centrifuged at 10,000 r / min for 10 minutes to collect the supernatant.
[0055] Example 7
[0056] The embodiment of the present invention provides a Tricholoma matsutake polypeptide. The only difference between the preparation method of the Tricholoma matsutake polypeptide and that of Example 1 is that neutral protease is used instead of alkaline protease in step (4).
[0057] Example 8
[0058] The embodiment of the present invention provides a Tricholoma matsutake polypeptide. The only difference between the preparation method of the Tricholoma matsutake polypeptide and that of Example 1 is that trypsin is used instead of alkaline protease in step (4).
[0059] Example 9
[0060] The embodiment of the present invention provides a Tricholoma matsutake polypeptide. The only difference between the preparation method of the Tricholoma matsutake polypeptide and that of Example 1 is that papain is used instead of alkaline protease in step (4).
[0061] Comparative Example 1
[0062] The comparative example of the present invention provides a Tricholoma matsutake polypeptide, and the preparation method of the Tricholoma matsutake polypeptide comprises the following steps:
[0063] (1) Dry the matsutake mushrooms at 50°C for 12 h, and sieve through a 10-mesh sieve to obtain matsutake mushroom powder;
[0064] (2) adding the pine mushroom powder in step (1) into deionized water at a solid-liquid ratio of 1:20, then heating to 60° C. and stirring for extraction for 2 h. After the extraction, centrifuging at 10,000 r / min for 10 min and collecting the supernatant;
[0065] (4) Add alkaline protease to the supernatant (the mass ratio of alkaline protease to pine mushroom powder is 1:5), adjust the pH to 9-10, heat to 55°C for enzymatic hydrolysis for 1.5 hours, and after the enzymatic hydrolysis is completed, heat to 100°C to inactivate the enzyme for 10 minutes, then cool, centrifuge, and filter through a 10 kDa filter membrane to obtain pine mushroom polypeptides.
[0066] Comparative Example 2
[0067] The comparative example of the present invention provides a Tricholoma matsutake polypeptide, and the preparation method of the Tricholoma matsutake polypeptide comprises the following steps:
[0068] (1) Dry the matsutake mushrooms at 50°C for 12 h, pass them through a 10-mesh sieve, and collect the sieved material to obtain matsutake mushroom powder;
[0069] (2) adding the pine mushroom powder in step (1) to a 0.1 mol / L sodium hydroxide aqueous solution at a solid-liquid ratio of 1:20, then heating to 60° C. and stirring for extraction for 2 h. After the extraction is completed, centrifuging at 10,000 r / min for 10 min and collecting the supernatant;
[0070] (4) Add alkaline protease to the supernatant (the mass ratio of alkaline protease to pine mushroom powder is 1:5), adjust the pH to 9-10, heat to 55°C for enzymatic hydrolysis for 1.5 hours, and after the enzymatic hydrolysis is completed, heat to 100°C to inactivate the enzyme for 10 minutes, then cool, centrifuge, and filter through a 10 kDa filter membrane to obtain pine mushroom polypeptides.
[0071] Comparative Example 3
[0072] The comparative example of the present invention provides a Tricholoma matsutake polypeptide, and the only difference between the preparation method of the Tricholoma matsutake polypeptide and Example 1 is that in step (2), betaine is used instead of matrine.
[0073] Comparative Example 4
[0074] The comparative example of the present invention provides a Tricholoma matsutake polypeptide, and the only difference between the preparation method of the Tricholoma matsutake polypeptide and Example 1 is that in step (2), betaine is used instead of matrine, and ethylene glycol is used instead of butanediol.
[0075] Comparative Example 5
[0076] The comparative example of the present invention provides a Tricholoma matsutake polypeptide, and the only difference between the preparation method of the Tricholoma matsutake polypeptide and Example 1 is that in step (2), L-carnitine is used instead of matrine.
[0077] Comparative Example 6
[0078] The comparative example of the present invention provides a Tricholoma matsutake polypeptide, and the preparation method of the Tricholoma matsutake polypeptide comprises the following steps:
[0079] (1) Dry the matsutake mushrooms at 50°C for 12 h, and sieve through a 10-mesh sieve to obtain matsutake mushroom powder;
[0080] (2) Preparation of NaDES solvent: matrine and propylene glycol were mixed in a molar ratio of 1:3, heated and stirred at 60° C. for 4 h to obtain a viscous liquid, and deionized water was then added to the viscous liquid to obtain a 5% NaDES solvent (i.e., the mass percentage of water in the NaDES solvent is 95%).
[0081] (3) The pine mushroom powder in step (1) was added to the NaDES solvent in step (2) at a solid-liquid ratio of 1:20, and then heated to 60°C and stirred for extraction for 3.5 hours. After the extraction, the mixture was centrifuged at 10,000 r / min for 10 minutes, the supernatant was collected and filtered through a 10 kDa filter to obtain pine mushroom polypeptide.
[0082] Comparative Example 7
[0083] The comparative example of the present invention provides a Tricholoma matsutake polypeptide, and the only difference between the preparation method of the Tricholoma matsutake polypeptide and Example 1 is that in step (3), glucosidase is used instead of alkaline protease.
[0084] Effect example
[0085] The effect examples of the present invention verify that the yields of proteins and Tricholoma matsutake polypeptides obtained by the preparation methods provided in the examples and comparative examples, as well as the antioxidant and anti-inflammatory properties of the prepared Tricholoma matsutake polypeptides, specifically include the following aspects:
[0086] 1. Yield of protein and yield of Tricholoma matsutake polypeptide: First, the total protein content of Tricholoma matsutake powder was determined by Kjeldahl nitrogen determination. The Tricholoma matsutake used in the embodiment of the present invention and the comparative example were from the same batch, and the total protein content was 19.7%. Then, the protein and Tricholoma matsutake polypeptide prepared in the embodiment and the comparative example were determined by Coomassie brilliant blue method and biuret method, respectively, and finally the yield of protein (supernatant after NaDES solvent extraction) and Tricholoma matsutake polypeptide was calculated.
[0087] 1) Protein content test method: prepare a bovine serum albumin standard solution with deionized water, take 1 mL of the standard solution and add 4 mL of Coomassie brilliant blue reagent, shake well, let stand for 30 min, use an ultraviolet spectrophotometer to measure at 595 nm, and draw a standard curve; take the Tricholoma matsutake protein solution before enzymatic hydrolysis and add deionized water to dilute it a certain multiple, then measure the protein content according to the standard solution test method, and calculate the protein yield according to the following formula:
[0088] Wherein, C is the protein concentration, n is the dilution multiple, V is the volume of Matsutake protein, and W is the total protein of Matsutake powder.
[0089] 2) Peptide content test method: 5% trifluoroacetic acid (TCA) was used as a solvent to prepare a glutathione standard solution. 2 mL of the standard solution was added to 3 ml of biuret reagent, shaken and allowed to stand for 10 min, and measured at 540 nm using an ultraviolet spectrophotometer to draw a standard curve. A certain amount of Tricholoma matsutake polypeptide was added to an equal amount of 10% TCA solution, shaken and allowed to stand for 10 min, and then centrifuged at 8000 rpm / min. The supernatant was diluted with a 5% TCA solution, and then the polypeptide content was determined according to the standard solution test method, and the polypeptide yield was calculated according to the following formula:
[0090] Wherein, C is the polypeptide concentration, n is the dilution multiple, V is the polypeptide volume, and W is the total protein of Matsutake powder.
[0091] 2. Antioxidant activity: Refer to GB / T39100-2020 "DPPH and ABTS method for determination of antioxidant activity of polypeptides" to evaluate the DPPH and ABTS free radical scavenging effects of the obtained Matsutake polypeptides;
[0092] 1) DPPH test: The obtained Tricholoma matsutake polypeptide was diluted to different multiples, and 1 mL of Tricholoma matsutake polypeptide solution was added to 3 mL of DPPH solution as the test group (A s ); 1 mL of Matsutake polypeptide solution was added with 3 mL of anhydrous ethanol as the control group (A c ); 1 mL of aqueous solution was added with 3 mL of anhydrous ethanol as the blank group (A b ). After the above three groups were fully mixed, they were reacted at room temperature in the dark for 30 minutes, and measured using an ultraviolet spectrophotometer at 517 nm, and the DPPH clearance rate was calculated according to the following formula:
[0093] The IC50 was then calculated.
[0094] 2) ABTS test: The obtained Matsutake polypeptide was diluted to different multiples, and 0.4 mL of Matsutake polypeptide solution was added to 3.6 mL of ABTS solution as the test group (A s ); 0.4 mL of aqueous solution was added with 3.6 mL of ABTS as the blank group (A b ). After the above two groups were fully mixed, they were reacted at room temperature in the dark for 5 minutes, and the results were measured using an ultraviolet spectrophotometer at 734 nm, and the ABTS clearance rate was calculated according to the following formula:
[0095] The IC50 was then calculated.
[0096] 3. Anti-inflammatory activity: Lipopolysaccharide (LPS)-induced human keratinocytes are a classic cell model for studying inflammatory factors. By comparing the differences in the secretion of IL-1α and IL-6 by human keratinocytes after administration of the modeling control and the test substance, the effect of Matsutake polypeptide on inhibiting the secretion of IL-1α and IL-6 was evaluated. After the keratinocytes were placed in a CO2 incubator (37°C, 5% CO2) for 24 hours, except for the blank group that added ordinary culture medium, the remaining samples were induced by adding culture medium containing 1μg / mL LPS, followed by incubation for 2 hours. After the incubation, the cell culture supernatant was collected and ELISA detection was performed according to the instructions of the ELISA kit to calculate the IL-1α and IL-6 contents.
[0097] 4. Anti-aging activity: UVA irradiation of fibroblasts leads to high expression of MMP-3, which destroys the cytoplasmic matrix, further destroys the structure of skin collagen and elastic fibers, and ultimately causes premature skin aging. After the fibroblasts were placed in a CO2 incubator (37°C, 5% CO2) for 24 hours, the working solution of the test substance was added according to the experimental group and incubated for 4 hours. After the incubation, except for the blank group, the rest were subjected to UVA (4.8J / cm 2 ) irradiation, after the irradiation, replace the culture medium with fresh test substance working solution, incubate for 24h, after the incubation, collect the cell culture supernatant, perform ELISA test according to the instructions of ELISA kit, and calculate the MMP-3 content.
[0098] The obtained results are shown in Table 1;
[0099] Table 1
[0100]
[0101]
[0102] Note: In the anti-inflammatory and anti-aging activity tests, the relative contents of IL-1α, IL-6 and MMP-3 in the positive control group were all 100%, and the samples in each embodiment and comparative example were the results obtained by the corresponding 0.3% Matsutake polypeptide test.
[0103] As can be seen from Table 1, when the preparation method provided by the present invention is adopted, the yield obtained is relatively high, among which the protein yield is above 20.6%, and the pine mushroom polypeptide yield is above 61.2%; and the obtained pine mushroom polypeptide has excellent antioxidant activity, anti-inflammatory activity and anti-aging activity; specifically, in the DPPH free radical scavenging test, the IC50 concentration of the pine mushroom polypeptide is lower than 19.8%, and in the ABTS free radical scavenging test, the IC50 concentration of the pine mushroom polypeptide is lower than 12.4%, and after LPS induction treatment, the relative contents of IL-1α and L-6 can still be maintained below 64.2% and 59.9%, and the relative content of MMP-3 after UVA induction is below 59.9%;
[0104] It can be seen from Example 1 and Comparative Examples 1-2 that when water or sodium hydroxide aqueous solution is used for extraction in the early stage, the protein yield obtained is extremely low; it can be seen from Example 1 and Comparative Examples 3-5 that when the NaDES solvent used is not the substance provided by the present invention, the effect of the present invention cannot be achieved; it can be seen from Example 1 and Comparative Example 6 that when proteolysis is not used, the antioxidant activity, anti-inflammatory activity and anti-aging activity of the obtained product are significantly reduced; it can be seen from Example 1 and Comparative Example 7 that when the enzyme used is not a protease, the effect of the present invention cannot be achieved.
[0105] In addition, the surface of the pine twig powder, the pine twig powder after water extraction in comparative example 1, the pine twig powder after sodium hydroxide aqueous solution extraction in comparative example 2, and the pine twig powder after NaDES solvent extraction in example 1 were observed, and the obtained SEM images were as follows: Figure 1 As shown, from Figure 1 It can be seen that the surface of the pine mushroom powder without any treatment is intact, has no obvious gaps, and is relatively smooth. After being treated with water, sodium hydroxide aqueous solution and NaDES solvent in Example 1, the surface of the pine mushroom powder is damaged to varying degrees, and the surface is relatively rough; moreover, the surface of the pine mushroom treated with NaDES solvent in Example 1 has pore structures of varying sizes, and the surface is extremely damaged; therefore, it can be inferred that the cell wall of the pine mushroom treated with NaDES solvent in Example 1 is relatively severely damaged, and the plant cell wall is damaged, so that the active components such as pine mushroom protein are dissolved, and the release of the functional components is promoted, thereby increasing the yield of pine mushroom protein.
[0106] Finally, it should be noted that the above embodiments are intended to illustrate the technical solution of the present invention rather than to limit the scope of protection of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention may be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.
Claims
1. A method for preparing a Tricholoma matsutake polypeptide, characterized in that: The preparation method comprises the following steps: (1) adding pine mushroom powder to a natural deep eutectic solvent and heating for extraction, centrifuging after the extraction, and collecting the supernatant; (2) adding protease to the supernatant for enzymatic hydrolysis, followed by enzyme inactivation, centrifugation, and ultrafiltration to obtain Tricholoma matsutake polypeptide; The raw materials of the natural low eutectic solvent include a hydrogen bond donor, a hydrogen bond acceptor and water, the hydrogen bond donor includes at least one of propylene glycol, butanediol and ethylene glycol, and the hydrogen bond acceptor includes matrine.
2. The preparation method according to claim 1, characterized in that: In the natural deep eutectic solvent, the molar ratio of the hydrogen bond acceptor to the hydrogen bond donor is 1:(0.1-5); And / or, in the natural deep eutectic solvent, the mass percentage of water is 40-95%.
3. The preparation method according to claim 2, characterized in that: The preparation method of the natural low eutectic solvent is as follows: a hydrogen bond donor and a hydrogen bond acceptor are mixed, heated to 30-60° C. and stirred for 3-6 hours, and then water is added and stirred evenly to obtain a natural low eutectic solvent.
4. The preparation method according to claim 1, characterized in that: In the step (1), the temperature of the heating extraction is 30-60° C., and the time of the heating extraction is 1-3 hours; And / or, in the step (1), the mass volume ratio of the pine mushroom powder to the natural low eutectic solvent is 1:(10-60).
5. The preparation method according to claim 1, characterized in that: The protease includes at least one of alkaline protease, neutral protease, trypsin and papain.
6. The preparation method according to claim 1, characterized in that: In the step (2), the enzymolysis temperature is 35-65°C and the enzymolysis time is 1-3h; And / or, the mass ratio of the protease to the pine mushroom powder is 1:(4-20).
7. The preparation method according to claim 1, characterized in that: In the step (2), the molecular weight of the ultrafiltration membrane used in ultrafiltration is 10 kDa.
8. A Tricholoma matsutake polypeptide, characterized in that: The Tricholoma matsutake polypeptide is prepared by the preparation method according to any one of claims 1 to 7.
9. Use of the Tricholoma matsutake polypeptide as claimed in claim 8 in the preparation of antioxidant, anti-inflammatory or anti-aging products.
